If you’re suffering from severe arthritis pain, you may be searching for the newest drugs to alleviate your symptoms. This article delves into the newest drugs for arthritis pain based on high-quality sources like the National Institutes of Health (NIH). By the end, you’ll better understand the cutting-edge treatments available for arthritis pain.

Medications to consider first:

• Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs help reduce pain and inflammation. Ibuprofen (e.g., Advil, Motrin) and naproxen (e.g., Aleve).
• Acetaminophen (Tylenol): a pain reliever that can help manage arthritis pain, particularly for those with mild to moderate pain or those who cannot take NSAIDs. However, it does not reduce inflammation.
• Corticosteroids: Corticosteroids, such as prednisone, help reduce inflammation and are used for short-term treatment in severe arthritis pain or disease flare-ups.
• Topical analgesics: Pain-relieving creams, gels, or patches containing ingredients like capsaicin, lidocaine, or NSAIDs can help manage localized arthritis pain.

However, if you have more severe arthritis pain, you may consider asking your doctor for other options, which include:

JAK Inhibitors: A New Class of Arthritis Pain Relief

Janus kinase (JAK) inhibitors are a promising new class of drugs for treating arthritis pain. These medications target specific enzymes involved in the inflammatory process, reducing inflammation and easing arthritis symptoms. Some of the newest JAK inhibitors on the market include:

• Rinvoq:  a (JAK) inhibitor used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Approved in 2019, Rinvok is a JAK inhibitor that has shown positive results in treating rheumatoid arthritis (source: NIH).
• Jyseleca is a Janus kinase (JAK) inhibitor used to treat severe rheumatoid arthritis in adults who have not responded well to other disease-modifying antirheumatic drugs (DMARDs).: Jyseleca has effectively reduced pain and inflammation in patients with rheumatoid arthritis (source: NIH).

Biologic Drugs

Biologic drugs derived from living organisms treat various forms of arthritis. However, new developments in this area continue to improve their effectiveness and expand their applications. The latest biologic drugs for arthritis pain include:

• Tremfya is a monoclonal antibody that targets interleukin-23 (IL-23), an inflammatory protein. It treats moderate to severe plaque psoriasis and active psoriatic arthritis in adults.
• Taltz is a monoclonal antibody that targets interleukin-17A (IL-17A), an inflammatory protein. It treats moderate to severe plaque psoriasis, ankylosing spondylitis, psoriatic arthritis, and non-radiographic axial spondyloarthritis in adults.

Biosimilars: Affordable Alternatives to Biologic Drugs

Biosimilars are a new wave of arthritis drugs similar to biologic medications but often more affordable. These drugs, derived from living cells, target specific proteins in the immune system that contribute to inflammation. The FDA has approved several biosimilars for arthritis pain management, including

• Inflectra: a biosimilar to the biologic drug Remicade (infliximab). It treats various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
• Erelzi is a biosimilar to the biologic drug Enbrel (etanercept). It treats rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.
• Amjevita is a biosimilar to the biologic drug Humira (adalimumab). It treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.

According to the NIH, biosimilars have shown comparable efficacy and safety to their biologic counterparts, making them a valuable option for people with severe arthritis.

Novel NSAIDs for Improved Relief

Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used to manage arthritis pain. Researchers continue to develop new NSAIDs to improve safety and efficacy. Some of the latest NSAIDs include:

• Arcoxia is a selective COX-2 inhibitor, a nonsteroidal anti-inflammatory drug (NSAID) that targets the COX-2 enzyme involved in inflammation and pain. It treats various inflammatory and painful conditions, such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and gout. Please note that Arcoxia is not approved for use in the United States but is available in several other countries.
• Vivlodex: a formulation of meloxicam. It is a nonsteroidal anti-inflammatory drug (NSAID) designed to relieve pain with a lower dose than traditional meloxicam. It is used to treat osteoarthritis pain in adults.

Emerging Therapies: Monoclonal Antibodies and Small Molecules

The future of arthritis pain management lies in the development of targeted therapies, such as monoclonal antibodies and small molecules. These cutting-edge treatments focus on specific pathways involved in inflammation, offering the potential for more effective and safer treatment options. Some examples of these emerging therapies include:

• Tanezumab: currently in clinical trials for the treatment of osteoarthritis pain. Preliminary results from NIH-funded research indicate that tanezumab may provide significant pain relief for patients with moderate to severe osteoarthritis.

• Bimekizumab: A monoclonal antibody, bimekizumab is being investigated for its potential in treating psoriatic arthritis (source: NIH).
• Fenebrutinib: This small molecule targets the Bruton’s tyrosine kinase (BTK) pathway and is under investigation for its potential in treating rheumatoid arthritis (source: NIH).

Remember to include other therapies in addition to medications

The best results often come when necessary medications are combined with other strategies such as:

1. Exercise and physical therapy: Regular exercise can help maintain joint flexibility, strengthen muscles, and reduce stiffness. Low-impact activities like swimming, cycling, or walking are especially beneficial. A physical therapist will develop a personalized plan to address your needs.
2. Weight management: Maintaining a healthy weight can reduce stress on weight-bearing joints and help alleviate arthritis pain.
3. Heat and cold therapy: Applying heat, such as warm towels or heating pads, can help ease joint pain and stiffness. Cold treatments like ice packs or compresses can help reduce inflammation and swelling.
4. Massage therapy: Massaging affected joints can help relieve pain and improve joint function. Consult with a licensed massage therapist experienced in working with arthritis patients.
5. Acupuncture: an ancient Chinese practice, involves inserting small thin needles into specific points on the body to manage pain. Some studies suggest it may provide relief for arthritis pain.
6. Dietary changes: Consuming a balanced, anti-inflammatory diet rich in fruits, vegetables, whole grains, lean protein, and healthy fats may help reduce inflammation and support overall joint health.
7. Supplements: Some people find relief with natural supplements, such as glucosamine, chondroitin, fish oil, or turmeric. However, please consult your healthcare provider before starting any supplements, as they can interact with medications or have side effects.
8. Assistive devices: Canes, braces, shoe inserts, or other assistive devices can help improve mobility and reduce joint strain.
9. Mind-body techniques: Practicing relaxation techniques, such as meditation, deep breathing, or yoga, can help manage pain by reducing stress and promoting well-being.
10. Hydrotherapy: Soaking in a warm bath or hot tub can help alleviate joint pain and stiffness.
11. Tai Chi: This gentle form of exercise, originating from ancient Chinese martial arts, can help improve flexibility, balance, and muscle strength, thereby reducing arthritis pain.

Conclusion

In conclusion, advancements in arthritis pain management have introduced a range of innovative treatment options, from JAK inhibitors and biosimilars to nerve growth factor inhibitors and novel drug combinations. These cutting-edge therapies provide hope for millions of people with arthritis seeking effective pain relief. As researchers continue to explore new avenues and refine existing treatments, the future of arthritis pain management looks promising. Remember, it is crucial to consult with a healthcare professional before starting any new treatment plan to ensure it is tailored to your specific needs and medical history. By staying informed and proactive about your treatment options, you can better manage your arthritis pain and lead a more comfortable, active life.

Find more stories on the Blog.

References:

1. National Institutes of Health (NIH). (2020). Arthritis. Retrieved from https://www.niams.nih.gov/health-topics/arthritis
2. U.S. Food and Drug Administration (FDA). (2019). FDA approves Rinvoq for rheumatoid arthritis. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-rinvoq-rheumatoid-arthritis
3. U.S. Food and Drug Administration (FDA). (2016). FDA approves Erelzi, a biosimilar to Enbrel. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-erelzi-biosimilar-enbrel
4. U.S. Food and Drug Administration (FDA). (2016). FDA approves Amjevita, a biosimilar to Humira. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-amjevita-biosimilar-humira
5. Mease, P. J., Chohan, S., & Garcia Fructuoso, F. J. (2020). Filgotinib for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology, 16(1), 1-9. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31799878/
6. Hochberg, M. C., Tive, L. A., Abramson, S. B., Vignon, E., Verburg, K. M., West, C. R., Smith, M. D., & Hungerford, D. S. (2016). When is osteonecrosis not osteonecrosis?: adjudication of reported serious adverse joint events in the tanezumab clinical development program. Arthritis & Rheumatology, 68(2), 382-391. Retrieved from https://pubmed.ncbi.nlm.nih.gov/26474159/